Upgrades
- Sharps Compliance (SMED) upgraded by Stifel from Hold to Buy
- Seagate (STX) upgraded by Stifel from Hold to Buy
- Britvic (BTVCF) upgraded by JPMorgan from Neutral to Overweight
- Outfront Media (OUT) upgraded by JPMorgan from Neutral to Overweight
- Solar Capital (SLRC) upgraded by JPMorgan from Neutral to Overweight
- WhiteHorse Finance (WHF) upgraded by JPMorgan from Underweight to Neutral
- Murphy USA (MUSA) upgraded by JPMorgan from Underweight to Neutral
- KKR (KKR) upgraded by Barclays from Equal Weight to Overweight
- Virtus Investment (VRTS) upgraded by Barclays from Equal Weight to Overweight
- Axalta Coating (AXTA) upgraded by BMO Capital from Market Perform to Outperform
- Remy Cointreau (REMYY) upgraded by Bernstein from Market Perform to Outperform
- CVR Energy (CVI) upgraded by Goldman Sachs from Sell to Neutral
- Ulta Beauty (ULTA) upgraded by Goldman Sachs from Neutral to Buy
- Colgate-Palmolive (CL) upgraded by RBC Capita from Sector Performl to Outperform
- Nike (NKE) upgraded by UBS from Neutral to Buy
- Colgate-Palmolive (CL) upgraded by Atlantic Equities from Neutral to Overweight
- Hess Corp. (HES) upgraded by Piper Sandler from Neutral to Overweight
- Monster Beverage (MNST) upgraded by Morgan Stanley from Equal Weight to Overweight
- Bluebird Bio (BLUE) upgraded by Evercore ISI from In Line to Outperform
Downgrades
- Swatch Group (SWGAY) downgraded by Citi from Buy to Neutral
- Electronic Arts (EA) downgraded by BMO Capital from Outperform to Market Perform
- Exxon Mobil (XOM) downgraded to by Goldman Sachs from Neutral to Sell
- Commonwealth Bank of Australia (CBAUF) downgraded by Credit Suisse to Underperform
- Engie SA (ENGIY) downgraded by Barclays from Overweight to Equal Weight
- BNP Paribas (BNPQY) downgraded by Berenberg from Hold to Sell
- Westpac (WBK) downgraded by Morgan Stanley from Equal Weight to Underweight
- Northrop Grumman (NOC) double-downgraded by Goldman Sachs from Buy to Sell
- Verizon (VZ) downgraded by Credit Suisse from Outperform to Neutral
- ViacomCBS (VIAC) downgraded by Credit Suisse from Outperform to Neutral
- Crispr Therapeutics (CRSP) downgraded by Evercore ISI from Outperform to In Line
Upgrades & Downgrades provided by The Fly at http://www.thefly.com. The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of TheFly’s services FREE for 14 days by clicking here.